Live feed08:00:00·357dPRReleasevia QuantisnowImmutep's Efti with KEYTRUDA® (pembrolizumab) & Chemotherapy Achieves High Response Rates in First-Line Non-Small Cell Lung CancerByQuantisnow·Wall Street's wire, on your screen.IMMP· Immutep LimitedHealth Care
